and Warrants to Purchase 3,000,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 7th, 2015 • ContraVir Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 7th, 2015 Company Industry JurisdictionContraVir Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Laidlaw & Company (UK) Ltd. is acting as representative (the “Representative”), (i) an aggregate of 5,000,000 shares (the “Firm Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company and (ii) five-year warrants to purchase shares of Common Stock at an exercise price of $4.25 per share, or warrants to purchase an aggregate of 3,000,000 shares of Common Stock (the “Firm Warrants” and the shares of Common Stock underlying the Firm Warrants, the “Firm Warrant Shares”). The Company has granted the Underwriters the option to purchase an aggregate of up to an additional (a) 750,000 shares (the “Option Shares”) of Common Stock and (b) five-year warrants (the “Optional Warrants”) to purchase up to an aggrega
Alexza Pharmaceuticals, Inc. Common Stock and Warrants Underwriting Agreement dated February 17, 2012 JMP SECURITIES LLCUnderwriting Agreement • February 17th, 2012 • Alexza Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 17th, 2012 Company Industry Jurisdiction
FORM OF UNDERWRITING AGREEMENTUnderwriting Agreement • April 23rd, 2007 • Banuestra Financial CORP • Functions related to depository banking, nec • Florida
Contract Type FiledApril 23rd, 2007 Company Industry Jurisdiction